Clinical Trials Directory

Trials / Completed

CompletedNCT04492579

Newborns Supplemented With Gentle-UHT Donor Milk

Neonates Supplemented With Gentle-UHT Donor Human Milk in the First Week of Life

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
31 (actual)
Sponsor
LactaLogics, Inc · Industry
Sex
All
Age
4 Days
Healthy volunteers
Accepted

Summary

This study evaluates the effects of providing breastfeeding mothers with Gentle-UHT donor human milk (GHM) after discharge to bridge the gap during delayed onset lactation, to support an exclusive human milk diet and continued breastfeeding through the infant's first week of life. The investigators aim to determine the safety of GHM, and if GHM provided to breastfeeding mothers of outpatient babies with early weight loss will ensure babies adequately gain weight according to age-matched controls.

Conditions

Interventions

TypeNameDescription
OTHERGentle-UHT donor human milk supplementationProviders referred mothers with newborns that fit the following criteria: exhibited insufficient milk supply, an infant with early weight loss born \>36 weeks gestation. Mother was given Gentle-UHT donor milk for supplementation, in addition to mother's own milk for the first week of the infant's life after hospital discharge.

Timeline

Start date
2018-08-03
Primary completion
2019-01-31
Completion
2020-01-17
First posted
2020-07-30
Last updated
2020-07-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04492579. Inclusion in this directory is not an endorsement.